ALSO Secures $105M Series B Funding to Revolutionize Low-Sodium Health & Wellness Options

ALSO, the Approved Low Sodium Option, is thrilled to announce a groundbreaking funding milestone, having successfully raised $105,000,000 to drive our mission further in revolutionizing the health and wellness landscape. As a non-for-profit initiative dedicated to empowering consumers to pursue healthier lifestyles and urging the food industry to offer more low sodium options, this generous funding injection serves as a catalyst for transformative change. Our goal has always been clear—to make healthy, low sodium, and organic foods accessible and convenient for widely diverse consumer populations who currently face challenges accessing nutritious options. With this substantial capital, ALSO will invest heavily in research and collaborative partnerships with producers, manufacturers, and policy makers to encourage the development and distribution of processed, packaged, and pre-prepared foods that meet recommended sodium reduction guidelines. Manufacturers who achieve these health benchmarks will proudly feature the ALSO logo on their packaging, empowering consumers with an unmistakable symbol of nutrition, safety, and quality. Additionally, these funds will help foster nationwide education initiatives to increase public awareness regarding the benefits of lower sodium diets, support advocacy efforts for stronger health advisory regulations, and work with food industry leaders to streamline the transition toward healthier products. In advancing our mission, ALSO is uniquely positioned to address the challenges of accessibility and convenience in healthy eating, and this funding represents a robust commitment to reshaping consumer habits while inspiring industry-wide innovation towards healthier choices. The momentum generated here promises a new era in public health, one where nutritious options are within easy reach and branded with trust.